Advanced search
Publication Cover
Expert Opinion on Pharmacotherapy Volume 10, 2009 - Issue 15
Submit an article Journal homepage
255
Views
5
CrossRef citations to date
0
Altmetric
Drug Evaluations

Dapagliflozin: where does it fit in the treatment of type 2 diabetes?

Vincent C Woo University of Manitoba, Health Science Centre, Section of Endocrinology and Metabolism, Department of Medicine, 838 – 715 McDermot Avenue, Winnipeg, Manitoba R3E 3P4, Canada +204 789 3433; +204 789 3988; [email protected]
, MD FRCPC
Pages 2527-2535 | Published online: 08 Sep 2009

Citations (5)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Niki Katsiki, Nikolaos Papanas & Dimitri P Mikhailidis. (2010) Dapagliflozin: more than just another oral glucose-lowering agent?. Expert Opinion on Investigational Drugs 19:12, pages 1581-1589.
Read now

Articles from other publishers (4)

S. Cangoz, Y.-Y. Chang, S. J. Chempakaseril, R. C. Guduru, L. M. Huynh, J. S. John, S. T. John, M. E. Joseph, R. Judge, R. Kimmey, K. Kudratov, P. J. Lee, I. C. Madhani, P. J. Shim, S. Singh, S. Singh, C. Ruchalski & R. B. Raffa. (2013) The kidney as a new target for antidiabetic drugs: SGLT2 inhibitors. Journal of Clinical Pharmacy and Therapeutics 38:5, pages 350-359.
Crossref
E. J. Verspohl. (2012) Novel Pharmacological Approaches to the Treatment of Type 2 Diabetes. Pharmacological Reviews 64:2, pages 188-237.
Crossref
Werner Kramer. (2011) Transporters, Trojan horses and therapeutics: suitability of bile acid and peptide transporters for drug delivery. Biological Chemistry 392:1-2.
Crossref
R.C.L. Page. 2011. A worldwide yearly survey of new data in adverse drug reactions. A worldwide yearly survey of new data in adverse drug reactions 889 908 .

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.